CEACAM1: Shielding the Liver Against Fibrosis

Overview

Journal Eur J Clin Invest

Publisher Wiley

Specialty General Medicine

Date 2024 Feb 29

PMID 38424027

Authors

Kezhong Zhang

Affiliations

Soon will be listed here.

Citing Articles

Tacrolimus (FK506) promotes placentation and maternal-fetal tolerance through modulating FASN-CEACAM1 pathway.

Meng X, Shi M, Qian J, Luo Y, Cui L, Li D Front Immunol. 2025; 16:1522346.

PMID: 40046057 PMC: 11879939. DOI: 10.3389/fimmu.2025.1522346.

References

Lee S, Heinrich G, Fedorova L, Al-Share Q, Ledford K, Fernstrom M . Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice. Gastroenterology. 2008; 135(6):2084-95. PMC: 2784638. DOI: 10.1053/j.gastro.2008.08.007. View

Helal R, Russo L, Ghadieh H, Muturi H, Asalla S, Lee A . Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. Metabolism. 2021; 121:154801. PMC: 8286970. DOI: 10.1016/j.metabol.2021.154801. View

Lee W . The CEACAM1 expression is decreased in the liver of severely obese patients with or without diabetes. Diagn Pathol. 2011; 6:40. PMC: 3104481. DOI: 10.1186/1746-1596-6-40. View

Son Y, Jeong Y, Lee K, Choi K, Kim S, Rhim B . Roles of MAPK and NF-kappaB in interleukin-6 induction by lipopolysaccharide in vascular smooth muscle cells. J Cardiovasc Pharmacol. 2008; 51(1):71-7. DOI: 10.1097/FJC.0b013e31815bd23d. View

Tilg H, Moschen A, Roden M . NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2016; 14(1):32-42. DOI: 10.1038/nrgastro.2016.147. View

Zaidi S, Asalla S, Muturi H, Russo L, Abdolahipour R, Belew G . Loss of CEACAM1 in hepatocytes causes hepatic fibrosis. Eur J Clin Invest. 2024; 54(7):e14177. PMC: 11153018. DOI: 10.1111/eci.14177. View

Najjar S, Yang Y, Fernstrom M, Lee S, DeAngelis A, Rjaily G . Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab. 2005; 2(1):43-53. DOI: 10.1016/j.cmet.2005.06.001. View

Poy M, Ruch R, Fernstrom M, Okabayashi Y, Najjar S . Shc and CEACAM1 interact to regulate the mitogenic action of insulin. J Biol Chem. 2001; 277(2):1076-84. DOI: 10.1074/jbc.M108415200. View

Abou-Rjaily G, Lee S, May D, Al-Share Q, DeAngelis A, Ruch R . CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation. J Clin Invest. 2004; 114(7):944-52. PMC: 518664. DOI: 10.1172/JCI21786. View

10.

Muturi H, Ghadieh H, Abdolahipour R, Stankus H, Belew G, Liu J . Loss of CEACAM1 in endothelial cells causes hepatic fibrosis. Metabolism. 2023; 144:155562. PMC: 10330196. DOI: 10.1016/j.metabol.2023.155562. View

11.

Loomba R, Friedman S, Shulman G . Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021; 184(10):2537-2564. DOI: 10.1016/j.cell.2021.04.015. View

12.

Poy M, Yang Y, Rezaei K, Fernstrom M, Lee A, Kido Y . CEACAM1 regulates insulin clearance in liver. Nat Genet. 2002; 30(3):270-6. DOI: 10.1038/ng840. View